Clear Search sequence regions

  • biosynthesis (1)
  • dna (1)
  • drug target (1)
  • inhibit (1)
  • insights (3)
  • ligand (1)
  • Sizes of these terms reflect their relevance to your search.

    Simocyclinones are antibiotics produced by Streptomyces and Kitasatospora species that inhibit the validated drug target DNA gyrase in a unique way, and they are thus of therapeutic interest. Structural approaches have revealed their mode of action, the inducible-efflux mechanism in the producing organism, and given insight into one step in their biosynthesis. The crystal structures of simocyclinones bound to their target (gyrase), the transcriptional repressor SimR, and the biosynthetic enzyme SimC7 reveal fascinating insight into how molecular recognition is achieved with these three unrelated proteins. © FEMS 2017.


    Mark J Buttner, Martin Schäfer, David M Lawson, Anthony Maxwell. Structural insights into simocyclinone as an antibiotic, effector ligand, and substrate. FEMS microbiology reviews. 2017 Nov 08

    PMID: 29126195

    View Full Text